Pharming Group's Q2 Earnings, Revenue Fall; 2026 Revenue Outlook Updated
MT Newswires Live
Jul 30
Pharming Group (PHAR) reported a Q2 earnings Thursday of $0.002 per diluted share, compared with $0.006 a year earlier.
Three analysts polled by FactSet expected $0.01.
Revenue for the quarter ended June 30 was $90.2 million, down from $93.2 million a year earlier.
Four analysts polled by FactSet expected $99.5 million.
The company updated its full-year 2026 revenue guidance to $375 million to $395 million, compared with its prior guidance of $405 million to $425 million. Analysts polled by FactSet are expecting $404 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.